Analysis: Drugmakers could find sympathetic US Supreme Court in drug pricing lawsuits

Analysis: Drugmakers could find sympathetic US Supreme Court in drug pricing lawsuits

U.S. President Joe Biden speaks about protecting Social Security, Medicare, and lowering prescription drug costs, during a visit to OB Johnson Park and Community Center, in Hallandale Beach, Florida, U.S. November 1, 2022. REUTERS/Kevin Lamarque/File Photo Acquire Licensing Rights Aug 31 (Reuters) – Drugmakers challenging a Biden administration program requiring them to negotiate with Medicare … Read more

Wall St Week Ahead Historically stormy month of September may test US stock rally

Wall St Week Ahead Historically stormy month of September may test US stock rally

The Wall Street entrance to the New York Stock Exchange (NYSE) is seen in New York City, U.S., November 15, 2022. REUTERS/Brendan McDermid/File Photo Acquire Licensing Rights NEW YORK, Aug 25 (Reuters) – U.S. stock investors are bracing for a potentially volatile September as the market faces key economic data reports, a Federal Reserve meeting … Read more

Obesity drug data could boost companies’ case for US coverage

Obesity drug data could boost companies’ case for US coverage

[1/3]An overweight woman sits on a chair in Times Square in New York, May 8, 2012. America’s obesity epidemic is so deeply rooted that it will take dramatic and systemic measures – from overhauling farm policies and zoning laws to, possibly, introducing a soda tax – to fix it, the influential… Read more Aug 10 … Read more

Quest Diagnostics launches Alzheimer’s blood test for consumers

Quest Diagnostics launches Alzheimer’s blood test for consumers

CHICAGO, July 31 (Reuters) – Quest Diagnostics (DGX.N) on Monday launched the first direct-to-consumer blood test to detect abnormal levels of beta amyloid, a key Alzheimer’s disease protein that can appear years before dementia symptoms arise. The $399 test, called AD-Detect, uses the same technology as a blood test the company began selling for use … Read more